Max Robotics — Global Service Robot Directory + US Certification

About

Kim Moretti is a leading researcher in urologic oncology, with a primary focus on prostate cancer epidemiology, treatment outcomes, and quality-of-life metrics across diverse populations. Her most significant contribution is her leadership in the Asian Prostate Cancer (A-CaP) study, a landmark Asia-wide initiative launched in 2015 that systematically surveys histopathologically diagnosed patients to clarify treatment patterns and disease distribution. The foundational report from this study, published in 2018, has garnered 12 citations and remains a critical reference for understanding regional disparities in prostate cancer management. More recently, she has advanced personalized surgical care through the international validation of predictive models for incontinence and erectile function after prostatectomy, published in 2025. This work, already cited 3 times, provides clinicians with evidence-based tools to counsel patients on post-surgical outcomes. Her research uniquely bridges large-scale epidemiological surveillance with practical, patient-centered prognostic tools, making her work essential for both population health strategies and individual treatment decisions.